Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Liaquat University of Medical & Health Sciences
With
University of Urbino "Carlo Bo"
This prospective, multicenter, randomized controlled clinical trial aims to evaluate the efficacy and safety of a food supplement containing Nigella sativa oil standardized to 10% thymoquinone (Nisatol®) in perimenopausal women diagnosed with metabolic syndrome and experiencing climacteric symptoms.
Fifty participants will be randomly assigned to either the intervention group (receiving 2 softgel capsules of Nisatol® daily for 4 months) or a control group following a Mediterranean diet. The primary endpoint is the change from baseline in metabolic and blood pressure parameters, including fasting glucose, lipid profile, cortisolemia, uricemia, and systolic/diastolic blood pressure. The study will also assess quality of life using the Greene Climacteric Scale and monitor treatment safety and tolerability.
The study addresses the need for non-hormonal, evidence-based interventions for managing metabolic and menopausal symptoms in midlife women.
Age
18–40
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Perimenopausal women aged 40-60 years
Presence of climacteric (menopausal) symptoms
Diagnosis of metabolic syndrome, defined as alteration of at least 3 of the following: